A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
Public ClinicalTrials.gov record NCT02261493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)
Study identification
- NCT ID
- NCT02261493
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 787 participants
Conditions and interventions
Conditions
Interventions
- OnabotulinumtoxinA Biological
- Normal Saline Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 26, 2014
- Primary completion
- Jun 2, 2015
- Completion
- Apr 19, 2016
- Last update posted
- Jul 24, 2017
2014 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Petrus Center for Aesthetic | Little Rock | Arkansas | 72205 | — |
| Westside Aesthetics | Los Angeles | California | 90025 | — |
| Eye Research Foundation | Newport Beach | California | 92663 | — |
| Steve Yoelin, MD Medical Associates, Inc. | Newport Beach | California | 92663 | — |
| Baumann Cosmetic & Research Institute | Miami | Florida | 33137 | — |
| Saint Louis University | St Louis | Missouri | 63122 | — |
| The Center For Dermatology Cosmetic and Laser Surgery | Mount Kisco | New York | 10549 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| The Center for Skin Research | Houston | Texas | 77056 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02261493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02261493 live on ClinicalTrials.gov.